These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells. De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J. Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344 [Abstract] [Full Text] [Related]
4. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity. Koistinen P, Wang C, Curtis JE, McCulloch EA. Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308 [Abstract] [Full Text] [Related]
5. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells. te Boekhorst PA, Löwenberg B, Sonneveld P. Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289 [Abstract] [Full Text] [Related]
6. The effects of cytosine arabinoside and GM-CSF in leukemic cells in vitro. Gao XZ, Yin MY, Preisler HD. Anticancer Res; 1989 Sep; 9(4):1053-5. PubMed ID: 2683990 [Abstract] [Full Text] [Related]
8. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs. Tafuri A, Lemoli RM, Chen R, Gulati SC, Clarkson BD, Andreeff M. Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244 [Abstract] [Full Text] [Related]
9. Effect of granulocyte-macrophage colony-stimulating factor on the metabolism of arabinosylcytosine triphosphate in blasts during therapy of patients with chronic myelogenous leukemia. Gandhi V, Du M, Kantarjian HM, Plunkett W. Leukemia; 1994 Sep; 8(9):1463-8. PubMed ID: 8090026 [Abstract] [Full Text] [Related]
10. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia. Cannistra SA, DiCarlo J, Groshek P, Kanakura Y, Berg D, Mayer RJ, Griffin JD. Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536 [Abstract] [Full Text] [Related]
11. Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside. Andreeff M, Tafuri A, Hegewisch-Becker S. Haematol Blood Transfus; 1990 Mar; 33():747-62. PubMed ID: 2323674 [Abstract] [Full Text] [Related]
12. The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture. Miyauchi J, Kelleher CA, Wong GG, Yang YC, Clark SC, Minkin S, Minden MD, McCulloch EA. Leukemia; 1988 Jun; 2(6):382-7. PubMed ID: 2453760 [Abstract] [Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia. Hiddemann W, Kiehl M, Zühlsdorf M, Busemann C, Schleyer E, Wörmann B, Büchner T. Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573 [Abstract] [Full Text] [Related]
14. Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells. Asano Y, Shibuya T, Okamura S, Yamaga S, Otsuka T, Niho Y. Cancer Res; 1987 Nov 01; 47(21):5647-8. PubMed ID: 3499216 [Abstract] [Full Text] [Related]
15. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor. Reuter C, Auf der Landwehr U, Schleyer E, Zühlsdorf M, Ameling C, Rolf C, Wörmann B, Büchner T, Hiddemann W. Leukemia; 1994 Feb 01; 8(2):217-25. PubMed ID: 8309245 [Abstract] [Full Text] [Related]
16. In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity. Van der Lely N, De Witte T, Wessels J, Raymakers R, Muus P, Preijers F. Ann Hematol; 1994 May 01; 68(5):225-32. PubMed ID: 7517190 [Abstract] [Full Text] [Related]
17. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia. Jahns-Streubel G, Reuter C, Unterhalt M, Schleyer E, Wörmann B, Büchner T, Hiddemann W. Leukemia; 1995 Nov 01; 9(11):1857-63. PubMed ID: 7475275 [Abstract] [Full Text] [Related]
18. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors. Carlo-Stella C, Mangoni L, Almici C, Frassoni F, Fiers W, Rizzoli V. Leukemia; 1990 Aug 01; 4(8):561-6. PubMed ID: 1697011 [Abstract] [Full Text] [Related]
19. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside. Koistinen P, Wang C, Yang GS, Wang YF, Williams DE, Lyman SD, Minden MD, McCulloch EA. Leukemia; 1991 Aug 01; 5(8):704-11. PubMed ID: 1715961 [Abstract] [Full Text] [Related]
20. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation. Murohashi I, Endho K, Nishida S, Yoshida S, Jinnai I, Bessho M, Hirashima K. Exp Hematol; 1995 Aug 01; 23(9):970-7. PubMed ID: 7543418 [Abstract] [Full Text] [Related] Page: [Next] [New Search]